Search

everythinglearnresearchcommunity

for

Search:↓

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Tinea capitis in adults is best treated with oral terbinafine, but other medications may be needed for resistant infections, and family and pets should be checked to prevent reinfection.

Retinoic acid is effective for treating eruptive vellus hair cysts.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

Epiduo® is an effective first-line acne treatment that reduces inflammation and combats antibiotic resistance.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Children and adults with Cushing's disease show different symptoms and males have more severe cases; surgery outcomes can be predicted by certain factors.

Experts discussed treatments for skin conditions in children, emphasizing hydration, cautious medication use, and early intervention for infections.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Referral rates for anaphylaxis patients improved significantly after implementing guidelines.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

SIG-1451 could be a promising new treatment for atopic dermatitis.

ALEP is a drug-triggered skin reaction with pustules that clears up in a week after stopping the drug.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

The meeting presented findings on effective treatments for various pet skin conditions and insights into the immune responses of dogs with atopic dermatitis.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Cimetidine is not a first-choice treatment for female hair loss, and there's no consistently successful treatment for this condition in men or normal hormone level women.